Xconomy

AUGUST 19, 2016

And once in a while, a defender uses his or her face, inadvertently, to block a ball spiked over the net. The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. Talk about sacrifice. If drug approval were an Olympic sport, rejections would also be high drama.

Technical Review 40

Technical Review Patents .Net Study 40

socalTECH

AUGUST 2, 2017

We have done both retrospective proof-of-concept and also prospective studies to prove out the concept, which is based on probably 100 papers worth of articles published in scientific journals. Where was the technology for this developed? The onus for us is really about the technical validation of the assay.

USC 100

USC Technical Review Startup Southern California 100

Xconomy

NOVEMBER 4, 2016

The Mayo Clinic cardiologist behind the report published a study earlier this year about long QT misdiagnosis leading to improper defibrillator implants. —Several other biotechs released ASH abstract data, and the net effect was a drop in most stocks. The false positives came from a misreading of the test results.

Research 40

Research Report Pricing Journal 40